Effect of Mitral Regurgitation on Thrombotic Risk in Patients With Nonrheumatic Atrial Fibrillation: A New CHA
- Resource Type
- Authors
- Sven L, Van Laer; Seppe, Verreyen; Koen M, Winkler; Hielko, Miljoen; Andrea, Sarkozy; Hilde, Heuten; Johan, Saenen; Paul, Van Herck; Caroline M, Van de Heyning; Hein, Heidbuchel; Marc J, Claeys
- Source
- The American journal of cardiology. 145
- Subject
- Aged, 80 and over
Male
Heart Diseases
Electric Countershock
Mitral Valve Insufficiency
Thrombosis
Comorbidity
Middle Aged
Severity of Illness Index
Risk Factors
Atrial Fibrillation
Prevalence
Humans
Atrial Appendage
Female
Heart Atria
Echocardiography, Transesophageal
Aged
- Language
- ISSN
- 1879-1913
The current study assessed the effect of mitral regurgitation (MR) on thrombotic risk in nonrheumatic atrial fibrillation (AF). AF carries a thrombotic risk related to left atrial blood stasis. The prevalence of atrial thrombosis, defined as the presence of left atrial appendage thrombus and/or left atrial spontaneous echo contrast grade2, was determined in 686 consecutive nonrheumatic AF patients without (adequate) anticoagulation scheduled for transesophageal echocardiography before electrical cardioversion and was related to the severity of MR adjusted for the CHA